Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment

Abdominal metastasis is relatively rare in dedifferentiated liposarcoma of the shoulder and back. Surgery is the best treatment option, whether it is radical or palliative surgery. Chemotherapy is the standard systemic treatment for advanced unresectable/metastatic patients, but the therapeutic effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin-Li, Gong, Jia-Yao, Xue, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299426/
https://www.ncbi.nlm.nih.gov/pubmed/34326745
http://dx.doi.org/10.1159/000512519
_version_ 1783726268555984896
author Wang, Xin-Li
Gong, Jia-Yao
Xue, Yan
author_facet Wang, Xin-Li
Gong, Jia-Yao
Xue, Yan
author_sort Wang, Xin-Li
collection PubMed
description Abdominal metastasis is relatively rare in dedifferentiated liposarcoma of the shoulder and back. Surgery is the best treatment option, whether it is radical or palliative surgery. Chemotherapy is the standard systemic treatment for advanced unresectable/metastatic patients, but the therapeutic effect is limited. Here, we treat advanced abdominal dedifferentiated liposarcoma through a comprehensive treatment method of targeting, surgery, and chemotherapy, which improves the quality of life of the patient, and shrinks the tumor significantly.
format Online
Article
Text
id pubmed-8299426
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-82994262021-07-28 Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment Wang, Xin-Li Gong, Jia-Yao Xue, Yan Case Rep Oncol Case Report Abdominal metastasis is relatively rare in dedifferentiated liposarcoma of the shoulder and back. Surgery is the best treatment option, whether it is radical or palliative surgery. Chemotherapy is the standard systemic treatment for advanced unresectable/metastatic patients, but the therapeutic effect is limited. Here, we treat advanced abdominal dedifferentiated liposarcoma through a comprehensive treatment method of targeting, surgery, and chemotherapy, which improves the quality of life of the patient, and shrinks the tumor significantly. S. Karger AG 2021-07-08 /pmc/articles/PMC8299426/ /pubmed/34326745 http://dx.doi.org/10.1159/000512519 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Wang, Xin-Li
Gong, Jia-Yao
Xue, Yan
Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment
title Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment
title_full Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment
title_fullStr Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment
title_full_unstemmed Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment
title_short Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment
title_sort obvious reduction of the tumor size in dedifferentiated liposarcoma in a lung metastasis patient receiving individualized treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299426/
https://www.ncbi.nlm.nih.gov/pubmed/34326745
http://dx.doi.org/10.1159/000512519
work_keys_str_mv AT wangxinli obviousreductionofthetumorsizeindedifferentiatedliposarcomainalungmetastasispatientreceivingindividualizedtreatment
AT gongjiayao obviousreductionofthetumorsizeindedifferentiatedliposarcomainalungmetastasispatientreceivingindividualizedtreatment
AT xueyan obviousreductionofthetumorsizeindedifferentiatedliposarcomainalungmetastasispatientreceivingindividualizedtreatment

Ejemplares similares